GE HealthCare's Phase I trial for a new manganese-based MRI contrast agent found it to be well-tolerated and a possible safer alternative to gadolinium-based agents, addressing safety and environmental concerns while offering similar imaging capabilities.
Annual mammograms are more effective in detecting breast cancer early and improving survival rates compared to less frequent screenings, despite concerns over false positives, according to new research.
Clarius Mobile Health and Usono have introduced a new wireless and wearable ultrasound imaging technology for researchers studying the anatomy of people while they move.
The Medical Imaging & Technology Alliance (MITA) sent letters to 11 state legislatures in support of eliminating or capping cost-sharing for supplemental and diagnostic screening exams for breast cancer.
